Chiara Mozzini Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

11/2015

Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiara Mozzini Research Topics

Disease

5	Inflammation (Inflammations) 02/2021 - 01/2008
3	Coronary Artery Disease (Coronary Atherosclerosis) 05/2021 - 03/2014
2	Myocardial Infarction 10/2022 - 02/2017
2	Atherosclerosis 09/2022 - 01/2008
1	Heart Failure 09/2023
1	Left Ventricular Outflow Obstruction 09/2023
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2023
1	Infections 10/2022
1	Progeria (Hutchinson Gilford Syndrome) 09/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2021
1	Virus Diseases (Viral Diseases) 02/2021
1	COVID-19 02/2021
1	Peripheral Arterial Disease 09/2018
1	Ischemia 09/2018
1	Stable Angina 01/2018
1	Unstable Angina 01/2018
1	Alcoholism (Alcohol Abuse) 10/2017
1	Brain Edema (Cerebral Edema) 10/2017
1	Pulmonary Edema 10/2017
1	Rhabdomyolysis 10/2017
1	Renal Insufficiency (Renal Failure) 10/2017
1	Seizures (Absence Seizure) 10/2017
1	Disseminated Intravascular Coagulation 10/2017
1	Cardiac Arrhythmias (Arrythmia) 10/2017
1	Liver Failure 10/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Emphysema 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2015
1	Diabetes Mellitus 11/2015
1	Liver Diseases (Liver Disease) 11/2015
1	Obesity 11/2015
1	Hypoxia (Hypoxemia) 11/2015
1	Thrombosis (Thrombus) 08/2014
1	Vascular Remodeling 01/2008
1	Hypertension (High Blood Pressure) 01/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2008

Drug/Important Bio-Agent (IBA)

4	NF-kappa B (NF-kB)IBA 09/2022 - 12/2009
4	AntioxidantsIBA 02/2021 - 01/2008
3	Phenobarbital (Luminal)FDA Link 10/2022 - 08/2014
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2021 - 09/2018
2	oxidized low density lipoproteinIBA 01/2018 - 01/2008
2	oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA 01/2016 - 03/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2023
1	omecamtiv mecarbilIBA 09/2023
1	Neprilysin (Neutral Endopeptidase)IBA 09/2023
1	SodiumIBA 09/2023
1	Cardiac MyosinsIBA 09/2023
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2023
1	Mineralocorticoid Receptor AntagonistsIBA 09/2023
1	Glucose (Dextrose)FDA LinkGeneric 09/2023
1	SymportersIBA 09/2023
1	MYK-461IBA 09/2023
1	ChromatinIBA 10/2022
1	Lamin Type A (Lamin A)IBA 09/2022
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	Uric Acid (Urate)IBA 05/2021
1	InflammasomesIBA 02/2021
1	NLR ProteinsIBA 02/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	InterleukinsIBA 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	SolutionsIBA 10/2017
1	Dacarbazine (DIC)FDA LinkGeneric 10/2017
1	Malondialdehyde (Propanedial)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016
1	Heme Oxygenase-1IBA 01/2016
1	ElementsIBA 03/2014
1	1- palmitoyl- 2- arachidonyl- 3- phosphorylcholineIBA 03/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2014
1	Metalloproteases (Metalloproteinases)IBA 01/2008
1	Atenolol (Tenormin)FDA LinkGeneric 01/2008
1	Nebivolol FDA Link 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2008
1	P-SelectinIBA 01/2008
1	E-SelectinIBA 01/2008
1	Endothelin-1 (Endothelin 1)IBA 01/2008
1	Thromboplastin (Tissue Factor)IBA 01/2008
1	HomocysteineIBA 01/2008
1	Fibrinogen (Factor I)FDA Link 01/2008

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2023
1	Secondary Prevention 05/2021